Page last updated: 2024-08-26

wr 151327 and Leukopenia

wr 151327 has been researched along with Leukopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bensely, D; Green, D; Schein, P	1

Other Studies

1 other study(ies) available for wr 151327 and Leukopenia

Article	Year
Preclinical evaluation of WR-151327: an orally active chemotherapy protector. Cancer research, 1994, Feb-01, Volume: 54, Issue:3 Topics: Administration, Oral; Amifostine; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Hematopoietic Stem Cells; Injections, Intraperitoneal; Leukemia P388; Leukocytes; Leukopenia; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Organothiophosphorus Compounds; Radiation-Protective Agents	1994

Article

Year

Preclinical evaluation of WR-151327: an orally active chemotherapy protector.

Cancer research, 1994, Feb-01, Volume: 54, Issue:3

Topics: Administration, Oral; Amifostine; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Hematopoietic Stem Cells; Injections, Intraperitoneal; Leukemia P388; Leukocytes; Leukopenia; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Organothiophosphorus Compounds; Radiation-Protective Agents

1994